TSXV:PTQ

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Protech Home Medical

Executive Summary

Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. More Details


Snowflake Analysis

Reasonable growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has Protech Home Medical's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: PTQ's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

4.5%

PTQ

-5.1%

CA Healthcare

-4.5%

CA Market


1 Year Return

57.3%

PTQ

-9.9%

CA Healthcare

-8.8%

CA Market

Return vs Industry: PTQ exceeded the Canadian Healthcare industry which returned -7.7% over the past year.

Return vs Market: PTQ exceeded the Canadian Market which returned -5.5% over the past year.


Shareholder returns

PTQIndustryMarket
7 Day4.5%-5.1%-4.5%
30 Day22.7%0.5%-3.8%
90 Day44.6%13.6%-3.3%
1 Year57.3%57.3%-6.1%-9.9%-5.5%-8.8%
3 Yearn/a-5.4%-18.3%0.5%-9.2%
5 Yearn/a-16.0%-33.7%28.7%8.9%

Price Volatility Vs. Market

How volatile is Protech Home Medical's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Protech Home Medical undervalued compared to its fair value and its price relative to the market?

187x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: PTQ (CA$1.56) is trading above our estimate of fair value (CA$0.35)

Significantly Below Fair Value: PTQ is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: PTQ is poor value based on its PE Ratio (180.1x) compared to the CA Healthcare industry average (67.9x).

PE vs Market: PTQ is poor value based on its PE Ratio (180.1x) compared to the Canadian market (16x).


Price to Earnings Growth Ratio

PEG Ratio: PTQ is poor value based on its PEG Ratio (3.1x)


Price to Book Ratio

PB vs Industry: PTQ is overvalued based on its PB Ratio (3.8x) compared to the CA Healthcare industry average (2.7x).


Next Steps

Future Growth

How is Protech Home Medical forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

55.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: PTQ's forecast earnings growth (57.5% per year) is above the savings rate (1.7%).

Earnings vs Market: PTQ's earnings (57.5% per year) are forecast to grow faster than the Canadian market (22.8% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: PTQ's revenue (10.9% per year) is forecast to grow faster than the Canadian market (5.8% per year).

High Growth Revenue: PTQ's revenue (10.9% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if PTQ's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Protech Home Medical performed over the past 5 years?

20.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: PTQ has a large one-off gain of CA$7.4M impacting its June 30 2020 financial results.

Growing Profit Margin: PTQ became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: PTQ has become profitable over the past 5 years, growing earnings by 20.7% per year.

Accelerating Growth: PTQ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: PTQ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (17.2%).


Return on Equity

High ROE: PTQ's Return on Equity (2.1%) is considered low.


Next Steps

Financial Health

How is Protech Home Medical's financial position?


Financial Position Analysis

Short Term Liabilities: PTQ's short term assets (CA$66.9M) exceed its short term liabilities (CA$30.1M).

Long Term Liabilities: PTQ's short term assets (CA$66.9M) exceed its long term liabilities (CA$21.3M).


Debt to Equity History and Analysis

Debt Level: PTQ's debt to equity ratio (33.8%) is considered satisfactory.

Reducing Debt: PTQ's debt to equity ratio has increased from 4.3% to 33.8% over the past 5 years.

Debt Coverage: PTQ's debt is well covered by operating cash flow (208.1%).

Interest Coverage: Insufficient data to determine if PTQ's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is Protech Home Medical current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate PTQ's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PTQ's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PTQ's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PTQ's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of PTQ's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.9yrs

Average management tenure


CEO

Greg Crawford

2.83yrs

Tenure

CA$652,452

Compensation

Mr. Gregory J. Crawford also known as Greg, has been Chief Executive Officer, President and Director of Protech Home Medical Corp. (also known as Patient Home Monitoring Corp.) ("PHM") since December 21, 2 ...


CEO Compensation Analysis

Compensation vs Market: Greg's total compensation ($USD863.74K) is above average for companies of similar size in the Canadian market ($USD170.92K).

Compensation vs Earnings: Greg's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Gregory Crawford
Chairman2.83yrsCA$652.45k4.28%
CA$ 7.5m
Hardik Mehta
Chief Financial Officer2.67yrsCA$556.32kno data
Jerry Kirn
Vice President of Operationsno datano datano data
Mark Miles
Vice President of Technologyno datano datano data
William Zehnder
Chief Strategy Officer & Investor Relationsno dataCA$308.24kno data
Leslie Becker
Executive Vice President of Business Development9.42yrsno datano data
William Frazier
Chief Medical Officer5yrsno datano data
Thomas Roehrig
Executive Vice President of Finance1.08yrsno datano data
Robert Grossman
Corporate Secretary8.75yrsno datano data

3.9yrs

Average Tenure

50yo

Average Age

Experienced Management: PTQ's management team is considered experienced (3.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Gregory Crawford
Chairman2.83yrsCA$652.45k4.28%
CA$ 7.5m
Mark Greenberg
Independent Director2.83yrsCA$120.00k0.052%
CA$ 90.9k
D. Ewing
Independent Non-Executive Director2.17yrsCA$50.00k0.25%
CA$ 434.2k
Steven Axelrod
Member of the Board of Advisors7yrsno datano data
Jim Booth
Member of the Board of Advisors7yrsno datano data

4.9yrs

Average Tenure

Experienced Board: PTQ's board of directors are considered experienced (4.9 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.9%.


Top Shareholders

Company Information

Protech Home Medical Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Protech Home Medical Corp.
  • Ticker: PTQ
  • Exchange: TSXV
  • Founded: 1993
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$174.478m
  • Shares outstanding: 111.84m
  • Website: https://www.protechhomemedical.com

Location

  • Protech Home Medical Corp.
  • 1019 Town Drive
  • Wilder
  • Kentucky
  • 41076
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
PTQTSXV (TSX Venture Exchange)YesNew Common SharesCACADDec 2017
A2PBDHDB (Deutsche Boerse AG)YesNew Common SharesDEEURDec 2017
PTQQ.FOTCPK (Pink Sheets LLC)YesNew Common SharesUSUSDDec 2017

Biography

Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP ma ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/10/28 23:49
End of Day Share Price2020/10/28 00:00
Earnings2020/06/30
Annual Earnings2019/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.